171 related articles for article (PubMed ID: 32884275)
1. Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.
Wakabayashi T; Hosohata K; Oyama S; Inada A; Ueno S; Kambara H; Iida T; Nakatsuji T; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2020; 16():741-747. PubMed ID: 32884275
[TBL] [Abstract][Full Text] [Related]
2. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
4. Safety profiles of new xanthine oxidase inhibitors: A post-marketing study.
Wakabayashi T; Ueno S; Nakatsuji T; Hirai T; Niinomi I; Oyama S; Inada A; Kambara H; Iwanaga K; Hosohata K
Int J Clin Pharmacol Ther; 2021 May; 59(5):372-377. PubMed ID: 33560211
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of vonoprazan compared with proton pump inhibitors: insight from a pharmacovigilance study.
Kambara H; Hosohata K; Nakatsuji T; Ueno S; Oyama S; Inada A; Niinomi I; Wakabayashi T; Iwanaga K
Pharmazie; 2020 Oct; 75(10):527-530. PubMed ID: 33305731
[TBL] [Abstract][Full Text] [Related]
6. Association between dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan.
Noguchi Y; Esaki H; Murayama A; Sugioka M; Koyama A; Tachi T; Teramachi H
Eur J Clin Pharmacol; 2020 Feb; 76(2):299-304. PubMed ID: 31822955
[TBL] [Abstract][Full Text] [Related]
7. Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Iida T; Kambara H; Uchida M; Sano Y; Hosohata K
Cureus; 2022 Sep; 14(9):e29383. PubMed ID: 36159360
[TBL] [Abstract][Full Text] [Related]
8. Current status of adverse event profile of tacrolimus in patients with solid organ transplantation from a pharmacovigilance study.
Kambara H; Oyama S; Inada A; Niinomi I; Wakabayashi T; Hosohata K
Int J Clin Pharmacol Ther; 2021 Dec; 59(12):753-759. PubMed ID: 34402788
[TBL] [Abstract][Full Text] [Related]
9. A Pharmacovigilance Study of Drug-Induced Glaucoma Utilizing the Japanese Adverse Event Reporting System.
Kozaru M; Iida T; Hosohata K
Clin Ophthalmol; 2023; 17():3645-3653. PubMed ID: 38050555
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database.
Niinomi I; Hosohata K; Oyama S; Inada A; Hirai T; Iwanaga K
Int J Clin Pharmacol Ther; 2020 Oct; 58(10):543-549. PubMed ID: 32631486
[TBL] [Abstract][Full Text] [Related]
11. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database.
Oyama S; Hosohata K; Inada A; Niinomi I; Mori Y; Yamaguchi Y; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2018; 14():1599-1604. PubMed ID: 30233195
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database.
Niinomi I; Hosohata K; Mori Y; Yamaguchi Y; Wakabayashi T; Uchida M; Iwanaga K
J Pharm Health Care Sci; 2019; 5():21. PubMed ID: 31608149
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database.
Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K
Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.
Inada A; Hosohata K; Oyama S; Niinomi I; Mori Y; Yamaguchi Y; Uchida M; Iwanaga K
Ther Clin Risk Manag; 2019; 15():59-64. PubMed ID: 30636879
[TBL] [Abstract][Full Text] [Related]
16. Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS.
Tian X; Chen L; Gai D; He S; Jiang X; Zhang N
Front Pharmacol; 2022; 13():851246. PubMed ID: 35401230
[No Abstract] [Full Text] [Related]
17. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
19. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance.
Wakabayashi T; Nakatsuji T; Kambara H; Niinomi I; Oyama S; Inada A; Ueno S; Uchida M; Iwanaga K; Iida T; Hosohata K
Curr Rev Clin Exp Pharmacol; 2022; 17(2):144-148. PubMed ID: 33588740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
